COMMUNIQUÉS West-GlobeNewswire

-
Capsa Healthcare Unveils the New Tryten P-Series: Engineering a Path to Better Care
25/09/2024 -
Spinogenix Announces Launch of a Phase 2 Clinical Trial Evaluating SPG302 for the Treatment of Schizophrenia
25/09/2024 -
Dallas Business Journal Recognizes USOSM COO Alisa Ulrey for Leadership
25/09/2024 -
Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study
25/09/2024 -
ClinicalTrials.EU platform rolled out across Europe
25/09/2024 -
Koelis Announces New Compact 3D Probe to Improve Workflow and Reprocessing
25/09/2024 -
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
25/09/2024 -
InBrain Pharma to Present Positive Results from Its DIVE-I Phase I/II Clinical Trial for Parkinson’s Disease at the Congress of Parkinson’s Disease and Movement Disorders from September 27 to October 1 in Philadelphia
25/09/2024 -
Sanner Group acquires Gilero to expand its global medical device offering
25/09/2024 -
SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout
25/09/2024 -
GoLiver Therapeutics is the winner of the France 2030 “innovation in Biotherapies and Bioproduction” call for its GOCLINICALS project, dedicated to a novel stem cell-based liver therapy
25/09/2024 -
QHSLab Secures Grant Sponsorship from a Global Leader in Consumer Health to Advance Digital Medicine Tools for Allergy Management in the Primary Care Setting
25/09/2024 -
Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
25/09/2024 -
GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment
25/09/2024 -
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
24/09/2024 -
Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2024 Conference Call for Monday, September 30, 2024
24/09/2024 -
LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
24/09/2024 -
Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day
24/09/2024 -
Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market
24/09/2024
Pages